Protection, Not Plumbing
New Approach Counteracts Stroke's Inflammation Piece
By Anette Breindl
Tuesday, July 26, 2011
Genentech Inc.'s tissue plasminogen activator (tPA), the only FDA-approved stroke drug, works by getting rid of the blood clot that is blocking blood flow.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.